WELLS FARGO & COMPANY/MN

Position in GMAB — Genmab A/S

CIK 72971 SAN FRANCISCO, CA

Back to GMAB Full portfolio

Position in GMAB

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$8,574,651

+$7,522,771 QoQ

Shares Held

319,592

+835.8% QoQ

Ownership

0.052%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 99.94242659390723.ToString("F0")% Shared 0.ToString("F0")% None 0.05757340609276828.ToString("F0")%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. GMAB ranks #22 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	744,995	$332,670,066
2	ALNY	Alnylam Pharmaceuticals, Inc.	342,763	$113,409,991
3	REGN	Regeneron Pharmaceuticals, Inc.	142,021	$109,731,102
4	HALO	Halozyme Therapeutics, Inc.	1,535,737	$99,254,679
5	INSM	INSMED Inc	597,384	$97,684,229
6	ASND	Ascendis Pharma A/S	154,199	$35,269,936
7	EXEL	Exelixis, Inc.	687,304	$29,478,466
8	ARGX	Argenx SE	38,104	$27,825,444

All Filings in GMAB

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,574,651	319,592	+835.8%	Shares	Defined	2026-05-11
2025-12-31	$1,051,880	34,152	+347.9%	Shares	Defined	2026-02-13
2025-09-30	$233,858	7,625	-21.9%	Shares	Defined	2025-11-13
2025-06-30	$201,743	9,765	+3.0%	Shares	Defined	2025-08-14
2025-03-31	$185,538	9,476	-96.7%	Shares	Defined	2025-05-13
2024-12-31	$5,908,525	283,111	-59.6%	Shares	Defined	2025-02-13
2024-09-30	$17,075,849	700,404	-3.2%	Shares	Defined	2024-11-13
2024-06-30	$18,181,679	723,505	-3.1%	Shares	Defined	2024-08-13
2024-03-31	$22,327,125	746,477	+34.0%	Shares	Defined	2024-05-10
2023-12-31	$17,739,080	557,132	-5.5%	Shares	Defined	2024-02-09
2023-09-30	$20,787,889	589,393	-7.4%	Shares	Defined	2023-11-13
2023-06-30	$24,188,839	636,381	-2.6%	Shares	Defined	2023-08-15
2023-03-31	$24,666,983	653,257	+2.7%	Shares	Defined	2023-05-12
2022-12-31	$26,946,389	635,828	-5.3%	Shares	Defined	2023-02-13
2022-09-30	$21,576,772	671,546	-0.5%	Shares	Defined	2022-11-14
2022-06-30	$21,917,851	674,603	+12.8%	Shares	Defined	2022-08-12
2022-03-31	$21,637,484	598,051	+18.7%	Shares	Defined	2022-05-16
2021-12-31	$19,934,480	503,905	-1.1%	Shares	Defined	2022-02-14
2021-09-30	$22,257,108	509,316	-1.1%	Shares	Defined	2021-11-15
2021-06-30	$21,033,450	515,147	-22.2%	Shares	Defined	2021-08-16
2021-03-31	$21,746,361	662,393	-9.8%	Shares	Defined	2021-05-13
2020-12-31	$29,862,817	734,452	+6.7%	Shares	Defined	2021-02-09
2020-09-30	$25,205,947	688,499	+5.2%	Shares	Defined	2020-11-05
2020-06-30	$22,177,987	654,411	-30.4%	Shares	Defined	2020-08-13
2020-03-31	$19,932,372	940,650	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.